$0.13
(Market cap
$69 Mln
Revenue (TTM)
$59 Mln
P/E Ratio
--
P/B Ratio
17.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.3 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
199.4
-
Debt to Equity
1.1
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
13,893,569
10 Years Aggregate
CFO
$-10.04 Mln
EBITDA
$-33.94 Mln
Net Profit
$-45.65 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Champions Oncology (CSBR)
| -23.6 | -1.5 | -7.8 | -25.2 | -5.9 | -12.7 | 13.0 |
|
BSE Sensex
| -10.1 | -2.5 | 2.0 | -5.0 | 5.2 | 5.7 | 10.3 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Champions Oncology (CSBR)
| -19.4 | 52.0 | 24.6 | -46.1 | -22.5 | 29.5 | 6.7 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Champions Oncology (CSBR)
|
5.3 | 68.5 | 59.4 | -1.2 | -1.6 | -30.5 | -- | 17.7 |
| 1.7 | 8.0 | 0.0 | -8.8 | -- | -373.2 | -- | 11.0 | |
| 3.1 | 118.4 | 0.0 | -10.1 | -- | -67.4 | -- | 8.4 | |
| 72.5 | 11,345.8 | 1,215.0 | 181.9 | 20.3 | 9 | 62.4 | 5.4 | |
| 2.0 | 18.3 | 0.0 | -22.1 | -- | -0 | -- | 1.8 |
Shareholding Pattern
View DetailsAbout Champions Oncology (CSBR)
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in... immune-deficient mice through TumorGraft Technology Platform. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey. Read more
-
CEO & Director
Dr. Ronnie Morris M.D.
-
CEO & Director
Dr. Ronnie Morris M.D.
-
Headquarters
Hackensack, NJ
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Champions Oncology (CSBR)
What is the current share price of Champions Oncology Inc (CSBR) Today?
The share price of Champions Oncology Inc (CSBR) is $5.28 (NASDAQ) as of 03-Sep-2026 16:00 EDT. Champions Oncology Inc (CSBR) has given a return of -5.92% in the last 3 years.
What is the current PB & PE ratio of Champions Oncology Inc (CSBR)?
Since, TTM earnings of Champions Oncology Inc (CSBR) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
-- |
-- |
2025 |
-- |
-- |
2024 |
-- |
-- |
2023 |
-- |
-- |
2022 |
-- |
-- |
What is the 52 Week High and Low of Champions Oncology Inc (CSBR)?
The 52-week high and low of Champions Oncology Inc (CSBR) are Rs 8.74 and Rs 4.85 as of 04-Sep-2026.
What is the market cap of Champions Oncology Inc (CSBR)?
Champions Oncology Inc (CSBR) has a market capitalisation of $ 69 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Champions Oncology Inc (CSBR)?
Before investing in Champions Oncology Inc (CSBR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.